Fish oil supplements are often marketed as a simple way to support brain health. But a new clinical trial suggests that, at least for older adults at elevated risk for Alzheimer’s disease, getting more omega-3s from a supplement may not be enough to protect memory or slow brain changes linked to cognitive decline.
In a two-year, placebo-controlled, double-blinded study published in eBioMedicine, researchers at Keck Medicine of USC tested whether high-dose fish oil supplements could improve brain health in older adults who rarely ate fish and were considered at higher risk for Alzheimer’s disease. The supplement appeared to reach the brain, but participants who took it did no better than those who took a placebo on memory tests, cognitive measures or brain scans tracking shrinkage in the hippocampus, a region important for memory.
That makes the study more revealing than a simple “supplement did not work” result. The researchers measured docosahexaenoic acid, or DHA, in cerebrospinal fluid, which surrounds the brain. After six months, DHA levels in the brain had increased by an average of 17%, suggesting the nutrient reached its intended target. Even so, that increase did not translate into measurable cognitive protection over the two-year study period.
“We all wish there was a silver bullet for preventing Alzheimer’s, but our findings showed that fish oil supplements do not appear to protect brain health,” said Hussein Naji Yassine, MD, director of the USC Center for Personalized Brain Health and lead investigator of the study. “While omega-3s play an important role in forming brain cell connections needed for cognition, our results do not support fish oil supplements as a preventive measure against Alzheimer’s.”
The trial included 365 adults ages 55 to 80 who rarely ate fish. About 47% carried APOE4, the strongest genetic risk factor for late-onset Alzheimer’s disease. Participants were randomly assigned to receive either a placebo or a daily fish oil supplement containing 2,000 milligrams of DHA, a key omega-3 fatty acid involved in brain function.
The study design matters because supplement claims are often built from observational research, where people who eat more fish or have higher omega-3 levels may differ from others in many ways. A randomized, placebo-controlled trial can more directly test whether a supplement produces the expected effect.
In this case, it did not. Participants who received DHA supplements did not perform better than the placebo group on memory or cognitive testing after two years. Brain scans also showed that the supplements did not prevent shrinkage of the hippocampus, which is often studied as a marker of brain aging and Alzheimer’s risk.
The findings do not mean omega-3s are unimportant. DHA is part of brain cell membranes and plays a role in brain development and function. Nor do the findings rule out benefits from eating fish or following a Mediterranean-style dietary pattern, which includes fish along with vegetables, fruits, legumes, whole grains, nuts and olive oil.
The study does raise questions about whether a stand-alone supplement can replicate the broader effects of a diet pattern, or whether timing, genetics, age or overall health may affect how the brain uses omega-3s.
Now, Yassine and his team are focused on why omega-3 supplements can reach the brain without producing clear brain-health benefits. Based on earlier work, they suspect omega-3s may work differently when consumed as part of a Mediterranean-style diet rather than as an isolated supplement.
“We’re focused on better understanding how the brain processes omega-3s and whether factors, such as poor health, dietary pattern, genetic risk and age, may change the brain’s ability to effectively absorb and use omega-3s,” Yassine said. “We are working to develop medications that may help the brain better utilize these nutrients to preserve cognitive function.”
The trial also does not answer every question about fish oil. It focused on older adults who rarely ate fish and had elevated Alzheimer’s risk. It tested a specific high-dose DHA supplement over two years. It did not test fish intake, Mediterranean-style diets or fish oil use for other medical reasons, such as triglyceride management under a clinician’s care.
But the results are relevant for anyone taking fish oil mainly as an Alzheimer’s prevention strategy. Americans spend more than $1 billion annually on fish oil supplements, according to the USC release, in part because of perceived brain-health benefits.
The study adds to a familiar pattern in nutrition research: Nutrients that appear promising in foods or blood markers do not always produce the same results when isolated in a capsule. For brain health, the larger pattern of care may matter more than one supplement.
Although broader lifestyle prevention was outside the scope of the study, Yassine pointed to the basics that continue to show up across brain-health research: regular movement, quality sleep and an overall balanced diet.
“Staying healthy throughout life remains the most powerful tool we have for reducing Alzheimer’s risk, including regular exercise, quality sleep and a balanced diet,” Yassine said.
The study was supported by the National Institutes of Health and the Alzheimer’s Drug Discovery Foundation.